ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novel non-opioid postsurgical pain implant launched
November 02, 2020Innocoll Holdings Limited has announced the commercial launch of the XARACOLL® (bupivacaine HCI) implant, a non-opioid treatment for acute post-surgical pain for up to 24 hours in adults following open inguinal hernia repair. -
FDA Approves Xaracoll (bupivacaine hydrochloride) Implant for Acute Postsurgical Pain Relief Following Open Inguinal Hernia Repair
September 23, 2020Innocoll Holdings Limited, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, announced today that the US Food and Drug Administration (FDA) has approved Xaracoll for acute postsurgical pain relief for up to 24 hours...
Pharma Sources Insight January 2025
